Maruichi Steel Tube Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Maruichi Steel Tube has a total shareholder equity of ¥365.6B and total debt of ¥5.3B, which brings its debt-to-equity ratio to 1.5%. Its total assets and total liabilities are ¥441.3B and ¥75.7B respectively. Maruichi Steel Tube's EBIT is ¥33.8B making its interest coverage ratio -12.5. It has cash and short-term investments of ¥102.7B.
Belangrijke informatie
1.5%
Verhouding schuld/eigen vermogen
JP¥5.34b
Schuld
Rente dekkingsratio | -12.5x |
Contant | JP¥102.74b |
Aandelen | JP¥365.56b |
Totaal verplichtingen | JP¥75.70b |
Totaal activa | JP¥441.25b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
If EPS Growth Is Important To You, Maruichi Steel Tube (TSE:5463) Presents An Opportunity
Oct 11Maruichi Steel Tube (TSE:5463) Has Affirmed Its Dividend Of ¥55.00
Sep 09Maruichi Steel Tube's (TSE:5463) Dividend Will Be ¥55.00
Aug 09Maruichi Steel Tube (TSE:5463) Has Affirmed Its Dividend Of ¥55.00
Jul 25Maruichi Steel Tube (TSE:5463) Has Announced A Dividend Of ¥55.00
Jul 11With EPS Growth And More, Maruichi Steel Tube (TSE:5463) Makes An Interesting Case
Jun 14Some Shareholders Feeling Restless Over Maruichi Steel Tube Ltd.'s (TSE:5463) P/E Ratio
May 01Maruichi Steel Tube (TSE:5463) Shareholders Will Want The ROCE Trajectory To Continue
Apr 09Maruichi Steel Tube (TSE:5463) Is Due To Pay A Dividend Of ¥69.50
Mar 03Analyse van de financiële positie
Kortlopende schulden: 5463's short term assets (¥227.0B) exceed its short term liabilities (¥45.8B).
Langlopende schulden: 5463's short term assets (¥227.0B) exceed its long term liabilities (¥29.9B).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 5463 has more cash than its total debt.
Schuld verminderen: 5463's debt to equity ratio has reduced from 3.8% to 1.5% over the past 5 years.
Schuldendekking: 5463's debt is well covered by operating cash flow (668.5%).
Rentedekking: 5463 earns more interest than it pays, so coverage of interest payments is not a concern.